{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:11:44Z","timestamp":1777777904712,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ecotoxicology and Environmental Safety"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ecoenv.2026.119817","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:28:39Z","timestamp":1770280119000},"page":"119817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic insights into sitagliptin-induced skin autoimmunity: Linking environmental drug exposure to IL-6 activation in bullous pemphigoid"],"prefix":"10.1016","volume":"310","author":[{"given":"Chun","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","article-title":"Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series","volume":"83","author":"Abdat","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib2","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1038\/s41467-025-62495-2","article-title":"IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes","volume":"16","author":"Bao","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ecoenv.2026.119817_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov."},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/12034754211027858","article-title":"Prominent role of type 2 immunity in skin diseases: beyond atopic dermatitis","volume":"26","author":"Belmesk","year":"2022","journal-title":"J. Cutan. Med Surg."},{"issue":"2","key":"10.1016\/j.ecoenv.2026.119817_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French pharmacovigilance database","volume":"175","author":"B\u00e9n\u00e9","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.ecoenv.2026.119817_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12032-007-0031-y","article-title":"The cell growth, morphology and immunocytochemistry of novel cell line established from a bone marrow of the patient with therapy-related myelodysplastic syndrome, entitled PC-MDS","volume":"24","author":"Bogdanovi\u0107","year":"2007","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2019.115366","article-title":"Spatial distribution and temporal trends of pharmaceuticals sorbed to suspended particulate matter of German rivers","volume":"171","author":"Boulard","year":"2020","journal-title":"Water Res."},{"key":"10.1016\/j.ecoenv.2026.119817_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.watres.2018.02.066","article-title":"Temporal and spatial variation in pharmaceutical concentrations in an urban river system","volume":"137","author":"Burns","year":"2018","journal-title":"Water Res."},{"key":"10.1016\/j.ecoenv.2026.119817_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.envint.2019.03.050","article-title":"Stereoisomeric profiling of chiral pharmaceutically active compounds in wastewaters and the receiving environment - a catchment-scale and a laboratory study","volume":"127","author":"Camacho-Mu\u00f1oz","year":"2019","journal-title":"Environ. Int."},{"issue":"11","key":"10.1016\/j.ecoenv.2026.119817_bib10","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1021\/acs.est.8b00945","article-title":"Widespread micropollutant monitoring in the Hudson river estuary reveals spatiotemporal micropollutant clusters and their sources","volume":"52","author":"Carpenter","year":"2018","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.165080","article-title":"Influence of biosolids and sewage effluent application on sitagliptin soil sorption","volume":"895","author":"Ccanccapa-Cartagena","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13577-019-00257-1","article-title":"Function of innate lymphoid cells in the immune-related disorders","volume":"32","author":"Dzopali\u0107","year":"2019","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.ecoenv.2026.119817_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102661","article-title":"The role of T cells in pemphigus vulgaris and bullous pemphigoid","volume":"19","author":"Fang","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.ecoenv.2026.119817_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jid.2022.08.041","article-title":"CXCL12\/CXCR4 axis drives the chemotaxis and differentiation of b cells in bullous pemphigoid","volume":"143","author":"Fang","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvman.2025.125708","article-title":"Exploring the toxicological impact of bisphenol a exposure on psoriasis through network toxicology, machine learning, and multi-dimensional bioinformatics analysis","volume":"385","author":"Feng","year":"2025","journal-title":"J. Environ. Manag."},{"issue":"17","key":"10.1016\/j.ecoenv.2026.119817_bib18","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1021\/acs.est.0c01454","article-title":"Ozonation of sitagliptin: removal kinetics and elucidation of oxidative transformation products","volume":"54","author":"Hermes","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chroma.2017.11.020","article-title":"Quantification of more than 150 micropollutants including transformation products in aqueous samples by liquid chromatography-tandem mass spectrometry using scheduled multiple reaction monitoring","volume":"1531","author":"Hermes","year":"2018","journal-title":"J. Chromatogr. A"},{"issue":"22","key":"10.1016\/j.ecoenv.2026.119817_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214101","article-title":"Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: clinical, laboratory, and histological features, and possible pathogenesis","volume":"23","author":"Hung","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ecoenv.2026.119817_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","article-title":"IL-6: a cytokine at the crossroads of autoimmunity","volume":"55","author":"Jones","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.ecoenv.2026.119817_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14789450.2020.1845654","article-title":"Multiomic analysis of cytokines in immuno-oncology","volume":"17","author":"Jurisic","year":"2020","journal-title":"Expert Rev. Proteom."},{"issue":"5","key":"10.1016\/j.ecoenv.2026.119817_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.autrev.2019.03.009","article-title":"Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid","volume":"18","author":"Kowalski","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ecoenv.2026.119817_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.ecoenv.2026.119817_bib25","article-title":"Exploring environmental triggers and viral associations in a case of severe bullous pemphigoid","volume":"17","author":"Lawlor","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ecoenv.2026.119817_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161927","article-title":"Understanding CD4(+) T cells in autoimmune bullous diseases","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ecoenv.2026.119817_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/14779072.2015.1046840","article-title":"Sitagliptin for type 2 diabetes: a 2015 update","volume":"13","author":"Lee","year":"2015","journal-title":"Expert Rev. Cardiovasc Ther."},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdermsci.2024.09.003","article-title":"Serum inflammatory biomarkers associated with disease severity and response to dupilumab treatment in bullous pemphigoid: a cluster analysis","volume":"116","author":"Li","year":"2024","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.ecoenv.2026.119817_bib29","article-title":"Follicular helper T Cells (Tfh) and IL-21 involvement in the pathogenesis of bullous pemphigoid","volume":"8","author":"Li","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.ecoenv.2026.119817_bib30","article-title":"JAK-STAT pathway, type I\/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib31","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1038\/s41467-024-50283-3","article-title":"Single-cell transcriptomics analysis of bullous pemphigoid unveils immune-stromal crosstalk in type 2 inflammatory disease","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ecoenv.2026.119817_bib32","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1111\/jocd.14797","article-title":"Global incidence and prevalence of bullous pemphigoid: a systematic review and meta-analysis","volume":"21","author":"Lu","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114421","article-title":"Auranofin ameliorates psoriasis-like dermatitis in an imiquimod-induced mouse by inhibiting of inflammation and upregulating FA2H expression","volume":"160","author":"Luo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ecoenv.2026.119817_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1586829","article-title":"Exploring the molecular mechanisms of huperzine a in the treatment of rosacea through network pharmacology, machine learning, and molecular dynamics simulations","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2332\/allergolint.13-LE-0669","article-title":"Maculopapular-type drug eruption caused by sitagliptin phosphate hydrate: a case report and mini-review of the published work","volume":"63","author":"Nakai","year":"2014","journal-title":"Allergol. Int."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jdermsci.2024.01.003","article-title":"Proteomic changes related to actin cytoskeleton function in the skin of vildagliptin-treated mice","volume":"113","author":"N\u00e4tynki","year":"2024","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.ecoenv.2026.119817_bib37","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1007\/s11033-021-06379-w","article-title":"Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review","volume":"48","author":"Obradovic","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.ecoenv.2026.119817_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/clinpract15090169","article-title":"Artificial intelligence in clinical medicine: challenges across diagnostic imaging, clinical decision support, surgery, pathology, and drug discovery","volume":"15","author":"Ogut","year":"2025","journal-title":"Clin. Pract."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1346-8138.15713","article-title":"Possible roles of CXCL13\/CXCR5 axis in the development of bullous pemphigoid","volume":"48","author":"Ohuchi","year":"2021","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.ecoenv.2026.119817_bib40","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s12325-025-03257-w","article-title":"GLP-1 receptor agonists, DPP-4 inhibitors and the skin-diabetes meets dermatology: a brief narrative review","volume":"42","author":"Pantazopoulos","year":"2025","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2025.01.103","article-title":"Characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated pemphigus patients: a retrospective analysis of 66 cases","volume":"93","author":"Pathak","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjd.20743","article-title":"The global incidence of bullous pemphigoid: a systematic review and meta-analysis","volume":"186","author":"Persson","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.ecoenv.2026.119817_bib43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/CM9.0000000000001312","article-title":"Blockade of complement activation in bullous pemphigoid by using recombinant CD55-CD46 fusion protein","volume":"134","author":"Qiao","year":"2021","journal-title":"Chin. Med J."},{"issue":"7","key":"10.1016\/j.ecoenv.2026.119817_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102790","article-title":"Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: a scoping review","volume":"17","author":"Reghunath","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"10.1016\/j.ecoenv.2026.119817_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40265-016-0686-9","article-title":"Sitagliptin: a review in type 2 diabetes","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ecoenv.2026.119817_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/acs.estlett.3c00108","article-title":"Pharmaceuticals account for a significant proportion of the extractable organic fluorine in municipal wastewater treatment plant sludge","volume":"10","author":"Spaan","year":"2023","journal-title":"Environ. Sci. Technol. Lett."},{"key":"10.1016\/j.ecoenv.2026.119817_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154295","article-title":"The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes","volume":"109","author":"Stoian","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.ecoenv.2026.119817_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/1346-8138.14741","article-title":"Analysis of patients with drug-induced pemphigoid using the Japanese adverse drug event report database","volume":"46","author":"Tanaka","year":"2019","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.ecoenv.2026.119817_bib50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.0022-202x.2001.01505.x","article-title":"Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells","volume":"117","author":"Teraki","year":"2001","journal-title":"J. Investig. Dermatol."},{"issue":"11","key":"10.1016\/j.ecoenv.2026.119817_bib51","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/M15-2568","article-title":"Risk for hospitalized heart failure among new users of saxagliptin, sitagliptin, and other antihyperglycemic drugs: A retrospective cohort study","volume":"164","author":"Toh","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ecoenv.2026.119817_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jid.2022.07.006","article-title":"Dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid is characterized by an altered expression of cytokines in the skin","volume":"143","author":"Tuusa","year":"2023","journal-title":"J. Investig. Dermatol."},{"issue":"3","key":"10.1016\/j.ecoenv.2026.119817_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1684\/ejd.2012.1706","article-title":"The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid","volume":"22","author":"Wakatabi","year":"2012","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib54","article-title":"Adaptive and innate immune pathogenesis of bullous pemphigoid: a review","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib55","article-title":"Recent advances in the genetics and innate immune cells of bullous pemphigoid","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib56","article-title":"Bullous pemphigoid: the role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ecoenv.2026.119817_bib57","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jid.2018.03.1515","article-title":"Identification of immunodominant Th2-cell epitopes in chinese patients with bullous pemphigoid","volume":"138","author":"Zhang","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.ecoenv.2026.119817_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113143","article-title":"Insight into the role of DPP-4 in fibrotic wound healing","volume":"151","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Ecotoxicology and Environmental Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147651326001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147651326001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:11:43Z","timestamp":1777489903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147651326001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":58,"alternative-id":["S0147651326001466"],"URL":"https:\/\/doi.org\/10.1016\/j.ecoenv.2026.119817","relation":{},"ISSN":["0147-6513"],"issn-type":[{"value":"0147-6513","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into sitagliptin-induced skin autoimmunity: Linking environmental drug exposure to IL-6 activation in bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Ecotoxicology and Environmental Safety","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecoenv.2026.119817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"119817"}}